AC Immune SA Stock Prediction
AI-powered sentiment analysis and prediction trends for ACIU, updated each market day.
ACIU AI Sentiment
AI sees no strong directional signal for AC Immune SA stock over the next 10 market days.
Prediction date: Aug. 11, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About AC Immune SA
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
Exchange
Market Cap
$236,114,689
Cap Tier
Employees
122
Listed Since
Sept. 23, 2016
Website
ACIU Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ACIU Volatility
AC Immune SA has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
